×

Growth Reports

Growth Reports
Report Name

Saliva Collection And Diagnostics Market Size, Share, Trends, Growth Outlook, and Opportunities to 2030- By Site Of Collection (Parotid Gland Collection, Submandibular/Sublingual Gland Collection, Others), By Application (Disease Diagnostics, Forensic Applications, Research), By End-user (Dentistry, Diagnostic Laboratories, Pharmaceutical & Biotechnology Companies, Research Institutes), Countries and Companies Report

Saliva Collection And Diagnostics Market is projected to register a 9.1% CAGR from 2024 to 2030. Geographically, the market is classified into major regions including North America, Europe, Asia Pacific, Latin America, Middle East, and Africa

Published On: October, 2024  |   Report Code: USD0003790  |   No. of Pages: 194

Antimicrobial Resistance Diagnostics Market Size, Share, Trends, Growth Outlook, and Opportunities to 2030- By Technology (Microbiology Culture, Immunoassay, PCR, NGS, Mass Spectrometry, Rapid & Point of Care, Others), By Pathogen, Drug Resistant Streptococcus Pneumoniae (DRSP), Drug Resistant Campylobacter (DRC), Clostridium Difficile (CD), Methicillin Resistant Staphylococcus Aureus (MRSA), Drug Resistant Neisseria Gonorrhoeae (DRNG), Drug Resistant Salmonella (DRNTS), Others), By End-User (Hospitals, Diagnostic Laboratories, Pharmaceutical & Biotechnology Companies, Others), Countries and Companies Report

Antimicrobial Resistance Diagnostics Market is projected to register a 6.9% CAGR from 2024 to 2030. Geographically, the market is classified into major regions including North America, Europe, Asia Pacific, Latin America, Middle East, and Africa

Published On: October, 2024  |   Report Code: USD0003789  |   No. of Pages: 190

Breast Cancer Liquid Biopsy Market Size, Share, Trends, Growth Outlook, and Opportunities to 2030- By Circulating Biomarkers (Circulating Tumor Cells (CTCs), Circulating Cell-free DNA (cfDNA), Extracellular Vesicles, Others), By Application (Early Detection/Screening, Diagnosis, Treatment Selection, Monitoring), Countries and Companies Report

Breast Cancer Liquid Biopsy is projected to register a 21.6% CAGR from 2024 to 2030, driven by North America, Europe, Asia Pacific, Latin America, Middle East, and Africa markets

Published On: October, 2024  |   Report Code: USD0003788  |   No. of Pages: 205

Latent Tuberculosis Infection Detection Market Size, Share, Trends, Growth Outlook, and Opportunities to 2030- By Test Type (Tuberculin Skin Test (TST), Interferon Gamma Released Assay (IGRA)), By Application (Household Contacts with Pulmonary TB, PLHIV, Others), By End-user (Diagnostic Laboratories, Hospitals/clinics, Academic & Research Institutions), Countries and Companies Report

Latent Tuberculosis Infection Detection Market is projected to register a 5.9% CAGR from 2024 to 2030. Geographically, the market is classified into major regions including North America, Europe, Asia Pacific, Latin America, Middle East, and Africa

Published On: October, 2024  |   Report Code: USD0003787  |   No. of Pages: 202

Cell Viability Assays Market Size, Share, Trends, Growth Outlook, and Opportunities to 2030- By Product (Consumables, Instruments), By Application (Drug Discovery and Development, Stem Cell Research, Diagnostics), By End-User (Biopharmaceutical Companies, Pharmaceutical Companies, CROs & CMOs, Research Institutes, Diagnostic Labs), Countries and Companies Report

Cell Viability Assays is projected to register a 11.1% CAGR from 2024 to 2030, driven by North America, Europe, Asia Pacific, Latin America, Middle East, and Africa markets

Published On: October, 2024  |   Report Code: USD0003784  |   No. of Pages: 205

Meningitis Diagnostic Testing Market Size, Share, Trends, Growth Outlook, and Opportunities to 2030- By Test Type (Latex Agglutination Tests, Lateral Flow Assay, PCR Assay, ELISA Tests, Culture Test, Others), By End-user (Hospitals, Diagnostic Centers, Others), Countries and Companies Report

Meningitis Diagnostic Testing Market is projected to register a 4.7% CAGR from 2024 to 2030. Geographically, the market is classified into major regions including North America, Europe, Asia Pacific, Latin America, Middle East, and Africa

Published On: October, 2024  |   Report Code: USD0003783  |   No. of Pages: 205

Carrier Screening Market Size, Share, Trends, Growth Outlook and Opportunities to 2030-by Type (Expanded Carrier Screening, Targeted Disease Carrier Screening), by Indication (Cystic Fibrosis, Tay-Sachs, Gaucher Disease, Sickle Cell Disease, Spinal Muscular Atrophy, Others), by Technology (DNA Sequencing, Polymerase Chain Reaction, Microarrays, Others), by End-Use (Hospitals, Laboratories, Physician Offices & Clinics, Others), and Companies Report

Carrier Screening Market is projected to reach at a 11.6 CAGR during the period of 2023-2030. Geographically, the market is classified into major regions such as North America, Europe, Asia Pacific, Latin America, Middle East and Africa.

Published On: October, 2024  |   Report Code: USD0003781  |   No. of Pages: 195

Liver Cancer Diagnostics Market Size, Share, Trends, Growth Outlook, and Opportunities to 2030- By Test Type (Laboratory Tests, Imaging, Endoscopy, Biopsy, Others), By End-user (Hospitals & Diagnostic Laboratories, Academic & Research Institutes, Pharmaceutical & CRO Laboratories), Countries and Companies Report

Liver Cancer Diagnostics Market is projected to register a 7.1% CAGR from 2024 to 2030. Geographically, the market is classified into major regions including North America, Europe, Asia Pacific, Latin America, Middle East, and Africa

Published On: October, 2024  |   Report Code: USD0003780  |   No. of Pages: 200

In Situ Hybridization Market Size, Share, Trends, Growth Outlook, and Opportunities to 2030- By Technology (FISH, CISH), By Probe (DNA, RNA), By Product (Instruments, Consumables & Accessories, Software, Services), By Application (Cancer, Cytogenetics, Developmental Biology, Infectious Diseases, Others), By End-user (Hospitals & Diagnostic Laboratories, CROs, Academic & Research Institutes, Others), Countries and Companies Report

In Situ Hybridization Market is projected to register a 10.8% CAGR from 2024 to 2030. Geographically, the market is classified into major regions including North America, Europe, Asia Pacific, Latin America, Middle East, and Africa

Published On: October, 2024  |   Report Code: USD0003779  |   No. of Pages: 202

Body Fluid Collection and Diagnostics Market Size, Share, Trends, Growth Outlook, and Opportunities to 2030- By Sample Type (Blood, Saliva, Urine, Cerebrospinal Fluid), By Product (Tests/Services, Kits & Consumables, Instruments), By Technology (Next Generation Sequencing (NGS), Polymerase Chain Reaction (PCR), Fluorescence in situ hybridization (FISH), Others), By Application (Prognostics & Screening, Diagnostics & Monitoring, Therapeutic Decision Making), Countries and Companies Report

Body Fluid Collection and Diagnostics Market is projected to register a 8.2% CAGR from 2024 to 2030. Geographically, the market is classified into major regions including North America, Europe, Asia Pacific, Latin America, Middle East, and Africa

Published On: October, 2024  |   Report Code: USD0003778  |   No. of Pages: 180

USD Analytics

USD Analytics is a leading information and analytics provider for customers across industries worldwide.


Useful Links

Contact Us